RevealDx, a Seattle-based startup that develops software aimed at improving the way healthcare professionals diagnose lung cancer, raised $4.25M in a new investment round. The company’s product uses machine learning techniques to assess the probability that a lung nodules found on chest CT scans are cancerous.
Seattle Startup RevealDx Lands $4.2M to Help Clinicians Diagnose Lung Cancer
Share: